Laboratory diagnosis of human seasonal and pandemic influenza virus infection

Medical Journal of Australia

Volumn 185, Issue 10 SUPPL., 2006, Pages

  Dwyer, Dominic E ^a   Smith, David W ^b   Catton, Michael G ^c   Barr, Ian G ^d  

^a WESTMEAD HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ANTIGEN DETECTION; ARTICLE; DIFFERENTIAL DIAGNOSIS; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION PREVENTION; INFLUENZA; LABORATORY DIAGNOSIS; MONITORING; NONHUMAN; NUCLEIC ACID ANALYSIS; SEASONAL VARIATION; SENSITIVITY AND SPECIFICITY; SEROLOGY; VACCINE PRODUCTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

EID: 34447552758     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00707.x     Document Type: Article

References (25)

1. Playford EG, Dwyer DE. Laboratory diagnosis of influenza virus infection. Pathology 2002; 34: 115-125.
2. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-1744.
3. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hays AJ, editors. Textbook of influenza. Oxford: Blackwell Science, 1998.
4. World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne [website]. http://www.influenzacentre.org (accessed Oct 2006).
5. Donaldson A, Lewis FA, Kennett ML, et al. The 1976 influenza epidemic in Melbourne. Med J Aust 1978; 2: 45-49.
6. Cruz JR, Quinonez E, Fernandez A, Devalte F. Isolation of viruses from nasopharyngeal secretions. Comparison of aspiration and swabbing as means of sample collection. J Infect Dis 1987; 156: 415-416.
7. Schmid ML, Kudesia G, Wake S, Read RC. Prospective comparative study of culture specimens and methods in diagnosing influenza in adults. BMJ 1998; 316: 275.
8. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12: 1203-1207.
9. Espy MJ, Smith TF, Harmon MW, Kendal AP. Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol 1986; 24: 677-679.
10. Tkácová M, Varecová E, Baker IC, et al. Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses. J Clin Microbiol 1997; 35: 1196-1198.
11. Ziegler T, Hall H, Sánchez-Fauquier A, et al. Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J Clin Microbiol 1995; 33: 318-321.
12. Ellis JS, Fleming DM, Zambon MC. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol 1997; 35: 2076-2082.
13. Schweiger B, Zadow I, Heckler R, et al. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 2000; 38: 1552-1558.
14. Stockton J, Ellis JS, Saville M, et al. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol 1998; 36: 2990-2995.
15. Li J, Chen S, Evans DH. Typing and subtyping using DNA microarrays and multiplex reverse transcriptase PCR. J Clin Microbiol 2001; 39: 696-704.
16. Young LC, Dwyer DE, Harris M, et al. Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/ 2002(H3N2)-like virus. Epidemiol Infect 2005; 133: 107-112.
17. The World Health Organization Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005; 11: 1515-1521.
18. Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001; 39: 134-138.
19. Sintchenko V, Gilbert GL, Coiera E, Dwyer DE. Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid results. J Clin Virol 2002; 25: 15-21.
20. Van Elden LJR, Nijhuis PS, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001; 39: 196-200.
21. Carman WF, Wallace LA, Walker J, et al. Rapid virological surveillance of community influenza infection in general practice. BMJ 2000; 321: 736-737.
22. de Jong MD, Thanh TT, Khanh THJ, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353: 2667-2672.
23. Rothbarth PH, Groen J, Bohnen AM, et al. Influenza virus serology - a comparative study. J Virol Methods 1999; 78: 163-169.
24. McKimm-Breschkin JL. Resistance of influenza viruses to neuraminidase inhibitors - a review. Antivir Res 2000; 47: 1-17.
25. Hayden FG. Antiviral resistance in influenza viruses - implications for management and pandemic response. N Engl J Med 2006; 354: 785-788.